Resistance to recombinant human erythropoietin therapy in haemodialysis patients

To better clarify the mechanism of resistance to recombinan thuman erythropoietin (rhEPO) therapy in haemodialysis patients, we studied systemic changes associated with resistance to rhEPO therapy in haemodialysis patients under rhEPO therapies, with particular interest on inflammation, leukocyte ac...

ver descrição completa

Detalhes bibliográficos
Autor principal: Costa, Elísio (author)
Outros Autores: Lima, Margarida (author), Rocha, Susana (author), Pereira, Petronila Rocha (author), Reis, Flávio (author), Castro, Elisabeth (author), Teixeira, Frederico (author), Miranda, Vasco (author), Faria, Maria do Sarmento (author), Loureiro, Alfredo (author), Quintanilha, Alexandre (author), Belo, Luís (author), Santos-Silva, Alice (author)
Formato: article
Idioma:eng
Publicado em: 2013
Assuntos:
Resistance to recombinant human erythropoietin
Haemodialysis
Erythropoietin
Inflammation
Iron status
Leukocyte activation
Eritropoietina humana recombinante
hemodiálise
inflamação
ciclo do ferro
activação leucocitária
Texto completo:http://hdl.handle.net/10400.14/9882
País:Portugal
Oai:oai:repositorio.ucp.pt:10400.14/9882

Texto Completo

http://hdl.handle.net/10400.14/9882

Registos relacionados